Increase of meningococcal serogroup Y cases in Europe A reason for concern?

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 5, 2012, Pages 685-688

  Bröker, Michael ^a   Jacobsson, Susanne ^b   DeTora, Lisa ^c   Pace, David ^d   Taha, Muhamed Kheir ^e  

^a GSK Marburg Vaccines and Diagnostics   (Germany)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Clinical Research and Development   (United States)

^d MATER DEI HOSPITAL   (Malta)

^e INSTITUT PASTEUR   (France)

Author keywords

Epidemiology; Europe; Meningococcal disease; Serogroup Y; Surveillance

Indexed keywords

MENINGOCOCCUS VACCINE;

ANTIBODY TITER; BACTERIAL STRAIN; DEVELOPING COUNTRY; DISEASE SURVEILLANCE; ENVIRONMENTAL EXPOSURE; EPIDEMIC; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INNATE IMMUNITY; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; NONHUMAN; NOTE; PREVALENCE; PUBLIC HEALTH PROBLEM;

EUROPE; HUMANS; INCIDENCE; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS, SEROGROUP Y; PREVALENCE;

EID: 84863659323     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20098     Document Type: Note

References (38)

1. Czumbel I. The epidemiology of invasive meningococcal disease in Europe, 2008 and 2009, 11. European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
2. Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, et al. Changes in Neisseria meningitidis disease epidemiology in the United States 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010; 50:184-91; PMID:20001736; http://dx.doi.org/10.1086/649209.
3. Hershey JH, Hitchcock W. Epidemiology and meningococcal serogroup distribution in the United States. Clin Pediatr 2010; 49:519-24; PMID:20507868; http://dx.doi.org/10.1177/0009922809347797.
4. Leimkugel J, Racloz V, Jacintho da Silva L, Pluschke G. Global review of meningococcal disease: A shifting etiology. J Bacteriol Res 2009; 1:6-18.
5. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000; 356:2159; PMID:11191548; http://dx.doi.org/10.1016/S0140-6736(00)03502-9.
6. Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 2005; 40:17-25; PMID:15614687; http://dx.doi.org/10.1086/426436.
7. Collard JM, Maman Z, Yacouba H, Djibo S, Nicolas P, Jusot JF, et al. Increase in Neisseria meningitidis serogroup W135, Niger, 2010. Emerg Infect Dis 2010; 16:1496-8; PMID:20735947; http://dx.doi.org/10.3201/eid1609.100510.
8. Harrison LH, Shutt KA, Schmink SE, Marsh JW, Harcourt BH, Wang X, et al. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era - United States 2000-2005. J Infect Dis 2010; 201:1208-24; PMID:20199241; http://dx.doi.org/10. 1086/651505.
9. Lourenco JA, Desai S, Tsang R. The changing epidemiology of invasive meningococcal disease in Canada, 1995 to 2009, 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
10. Sáfadi MAP, Cintra OAL. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol Res 2010; 32:263-71; PMID:20406604; http://dx.doi.org/10.1179/ 016164110X12644252260754.
11. Inés Agudelo C, Sanabria OM, Ovalle MV. Serogroup Y meningococcal disease, Colombia. Emerg Infect Dis 2008; 14:990-1; PMID:18507927; http://dx.doi.org/10.3201/eid1406.071357.
12. Trotter C, Findlow H, Chadha H, Townsend K, Thompson D, Mabey L, et al. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
13. Skoczynka A, Kuch A, Wasko I, Golebiewska A, Ronkieicz P, Markowska M, et al. Surveillance of invasive meningococcal disease in Poland in 2010. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
14. Heuberger S, Mikula C, Orendi U, Springer B. Austria 2010, epidemiology and surveillance of meningococcal disease. Austria 2010, epidemiology and surveillance of meningococcal disease. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
15. Gray SJ, Campbell H, Marsh WJ, Carr AD, Newbold LS, Mallard RH, et al. The epidemiology and surveillance of meningococcal disease in England and Wales. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
16. Jacobsson S, Mölling P, Thulin Hedberg S, Lepp T, Unemo M, Fredlund H, et al. Invasive meningococcal disease in Sweden 2010. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
17. Kozakova J, Musilek M, Vackova Z, Kriz P. Invasive meningococcal disease in the Czech Republic in 2010. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
18. Stragier P, Carion F, Bertrand S. Invasive meningococcal disease: recent trends in Belgium. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
19. Lambertsen L, Rasmussen JN, Valentiner-Branth P, Hoffmann S. Laboratory and epidemiological surveillance of invasive meningococcal disease in Denmark 2009 and 2010. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
20. Parant du Chatelet I, Taha MK. Invasive meningococcal disease in France, 2009-2010. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
21. Koroleva IS, Beloshiskij IM, Zakroeva IM, Koroleva MA. Epidemiology of invasive meningococcal disease in Russian Federation. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
22. th Joint Congress of the European Society of Clinical Microbiology and Infectious Diseases (ECCMID) and the International Society of Chemotherapy (ICC), Milan, Italy, May 7-10, 2011.
23. th Joint congress of the European Society of Clinical Microbiology and Infectious Diseases (ECCMID) and the International Society of Chemotherapy (ICC), Milan, Italy, May 7-10, 2011.
24. Titova L, Samodova O, Buzinov R, Gordienko T. Epidemiology of meningococcal infection in Arkhangelsk Oblast. EpiNorth 2010; 11:10-5.
25. Tzanakaki G. National Meningococcal Reference Laboratory Report 2010, Athens, unpublished data.
26. Hedberg ST, Törös B, Fredlund H, Olcén P, Mölling P. Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. Euro Surveill 2011; 16:19885; PMID:21679677.
27. Rentero Z, Romero Gomez MP. Enfermedad meningococica invasiva por Neisseria meningitidis del serogroup Y. Enferm Infecc Microbiol Clin 2011; 29:550-9; PMID:21497422; http://dx.doi.org/10.1016/j.eimc.2011.01.017.
28. Zenone T, Sartre J, Gibert C, Gallen-Labbé F. Infection with Neisseria meningitidis serogroup Y revealing systemic lupus erythematosus. Lupus 2010; 19:1676-8; PMID:20667940; http://dx.doi.org/10.1177/0961203310376954.
29. Trotter C, Findlow H, Chadha H, Townsend K, Thompson D, Mabey L, et al. Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009. 11 European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-20, 2011.
30. Bidmos F, Neal KR, Oldfield NJ, Turner DPJ, Ala'Aldeen DAA, Bayliss CD. Rapid clonal expansion,persistence and clonal replacement of meningococcal carriage isolates in a 2008 university student cohort. J Clin Microbiol 2011; 49:506-12; PMID:21123536; http://dx.doi.org/10.1128/JCM.01322-10.
31. Trotter C, Findlow H, Chadha H, Townsend K, Thompson D, Maybe L, et al. Seroprevlence of serum bactericidal antibodies against group W-135 and Y meningococci in England and Wales in 2009. European Monitoring Group on Meningococci (EMGM), Ljubljana, Slovenia, May 18-29, 2011.
32. Basustaoglu AC, Bedir O, Yilmaz S, et al. Askere Yeni Tatilan Turk Askerlerinde Neisseria meningitidis Nazofaringeal Tasiyicilik Orani ve Serogruplari. TAF Prev Med Bull 2011; 10:447-50.
33. Chiappini E, Venturini E, Bonsignori F, Galli L, de Martino M, Serogroup C. Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign. Acta Paediatr 2010; 99:1609-14; PMID:20545931; http://dx.doi.org/10.1111/j.1651-2227.2010.01908.x.
34. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 2010; 9:285-98; PMID:20218857; http://dx.doi.org/10.1586/erv.10.3.
35. Campbell H, Andrews N, Borrow R, Trotter C, Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol 2010; 17:840-7; PMID:20219881; http://dx.doi.org/10.1128/CVI.00529-09.
36. Maiden MC, Ibarz-Pavón AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 2008; 197:737-43; PMID:18271745; http://dx.doi.org/10.1086/527401.
37. Press report of the Austrian Ministry for Health, August 22, 2011. http://bmg.gv.at/ home/Presse/Pressemeldungen/Stoeger-plant-Kinder impf konz ept - zu -e rwe it e rn-Neue -Gratis-Impfungen-gegen-Pneumokokken-und-Meningokokken Accessed August 24, 2011.
38. Bollettino uffeciale della Regione Basilicata (Pediatric immunization calendar for the Italian region Basilicata) 10311-2. http://buronline.regione. basilicata.it/Bur-2009/ricerca.aspx